United States · FDA National Drug Code directory
Haloperidol decanoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1851_04562fb6-450e-4345-ac35-6bc8c940682a
- Product NDC
- 70771-1851
- Form
- INJECTION
- Composition / generic term
- Haloperidol decanoate
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191114
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOPERIDOL DECANOATE — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (70771-1851-6) / 1 mL in 1 VIAL, SINGLE-DOSE · 70771-1851-6
- 3 VIAL, SINGLE-DOSE in 1 CARTON (70771-1851-9) / 1 mL in 1 VIAL, SINGLE-DOSE · 70771-1851-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →